Advertisement

Topics

Immune Pharma's Oncology Subsidiary, Cytovia, Inc. Provides Update To Proposed Pint Pharma Transaction: Substantial Agreement Reached On Material Terms Of The Licensing And Commercialization Of Ceplene In Latin America

20:00 EDT 28 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Immune Pharma's Oncology Subsidiary, Cytovia, Inc. Provides Update To Proposed Pint Pharma Transaction: Substantial Agreement Reached On Material Terms Of The Licensing And Commercialization Of Ceplene In Latin America

NEXT ARTICLE

More From BioPortfolio on "Immune Pharma's Oncology Subsidiary, Cytovia, Inc. Provides Update To Proposed Pint Pharma Transaction: Substantial Agreement Reached On Material Terms Of The Licensing And Commercialization Of Ceplene In Latin America"

Advertisement
Quick Search
Advertisement
Advertisement